ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,974.07
      0.73%
      US Tech 100
      20,918.00
      0.83%
      Dow Jones
      42,906.95
      0.16%
      Brent Oil
      72.70
      -0.02%
      Bitcoin
      94,721.43
      -0.41%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Biophytis (ALBPS) Quote

      Biophytis

      Biophytis (ALBPS)

      EU
      0.327
      -0.013
      (-3.82%)
      Closed December 23 11:30AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      0.327
      Bid
      0.3251
      Ask
      0.34
      Volume
      28,356
      0.327 Day's Range 0.35
      0.0021 52 Week Range 1.40
      Market Cap
      96.695M
      Previous Close
      0.34
      Open
      0.342
      Last Trade
      1261
      @
      0.327
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      38,968
      Shares Outstanding
      295,702,507
      Dividend Yield
      -
      PE Ratio
      -5.73
      Earnings Per Share (EPS)
      -0.06
      Revenue
      -
      Net Profit
      -17.03M

      About Biophytis

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.biophytis.com
      Headquarters
      Paris, Paris, Fra
      Founded
      -
      Biophytis is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker ALBPS. The last closing price for Biophytis was 0.34 €. Over the last year, Biophytis shares have traded in a share price range of 0.0021 € to 1.40 €.

      Biophytis currently has 295,702,507 shares outstanding. The market capitalization of Biophytis is 100.54 € million. Biophytis has a price to earnings ratio (PE ratio) of -5.73.

      Ask ADVFN Intelligence (AI)

      ALBPS Latest News

      More News

      ADRs Close Lower; Fanhua Slips 16%

      This article was automatically generated by MarketWatch using technology from Automated Insights. International stocks trading in New York closed lower Friday, as the S&P/BNY Mellon index of...

      December 15 2023
      Dow Jones News

      Biophytis Shares Drop 11% After Request for Meeting With FDA on Covid-19 Treatment

      By Chris Wack Biophytis shares fell 11% to $2.40 after the company said it has filed for a pre-submission meeting request with the Food and Drug Administration to discuss filing for emergency use...

      July 20 2023
      Dow Jones News

      Biophytis to Restate Previously Issued Financial Statements

      PARIS and CAMBRIDGE, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS) (the “Company” or “Biophytis”), a clinical-stage biotechnology company...

      October 06 2021
      GlobeNewswire Inc.

      Biophytis Receives FDA IND Clearance for COVA, a Phase 2/3 Clinical Trial with Sarconeos (BIO101) for the Treatment of Patien...

      PARIS and CAMBRIDGE, Mass., July 02, 2020 (GLOBE NEWSWIRE) -- Biophytis SA (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company specialized in the development of drug...

      July 02 2020
      GlobeNewswire Inc.

      Biophytis Announces Results of 2019 Annual General Meeting of Shareholders

      All resolutions within the competence of the Ordinary General Meeting adoptedSecond notice to reconvene the Extraordinary General Meeting to be held in the coming weeks PARIS and CAMBRIDGE...

      June 28 2019
      GlobeNewswire Inc.

      Biophytis Enters into a Collaboration with the French Muscular Dystrophy Association (AFM-Telethon)

      Provides funding for additional preclinical experiments and for the MYODA preparations for the clinical study in Duchenne muscular dystrophy (DMD) PARIS and CAMBRIDGE, Mass., June 13, 2019...

      June 13 2019
      GlobeNewswire Inc.

      Biophytis Expands Daniel Schneiderman’s Role to Group Chief Financial Officer

      PARIS and CAMBRIDGE, Mass., June 07, 2019 (GLOBE NEWSWIRE) -- Biophytis SA (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development of therapeutics for...

      June 07 2019
      GlobeNewswire Inc.

      Biophytis Announces Publication of its 2018 Annual Report

      Files 2018 Annual Report with the AMFProvides first quarter 2019 financial statementsEnters into intellectual property agreement with Stanislas Veillet PARIS and CAMBRIDGE, Mass., May 22, 2019...

      May 22 2019
      GlobeNewswire Inc.

      Biophytis Files Registration Statement for Proposed Initial Public Offering in the United States

      PARIS and CAMBRIDGE, Mass., May 22, 2019 (GLOBE NEWSWIRE) -- Biophytis (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development of therapeutics for...

      May 22 2019
      GlobeNewswire Inc.

      Biophytis Reports Annual 2018 Financial Results and Provides Operational Update

      Clinical execution and advancement of our SARA program, including initiation of the SARA-INT Phase 2b clinical trial for sarcopeniaLaunch of our MYODA program for Duchenne muscular dystrophy...

      March 11 2019
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.001-0.304878048780.3280.350.3201247340.33111642DE
      40.02790.30.350.293227980.31308389DE
      12-0.0705-17.73584905660.39750.42990.28389680.32329525DE
      26-0.373-53.28571428570.70.840.28486870.48451222DE
      520.32153500.0061.40.002166156300.00597859DE
      156-0.143-30.42553191490.471.40.002154671290.02950031DE
      2600.11755.71428571430.212.730.002147291930.27487221DE

      ALBPS - Frequently Asked Questions (FAQ)

      What is the current Biophytis share price?
      The current share price of Biophytis is 0.327 €
      How many Biophytis shares are in issue?
      Biophytis has 295,702,507 shares in issue
      What is the market cap of Biophytis?
      The market capitalisation of Biophytis is EUR 100.54M
      What is the 1 year trading range for Biophytis share price?
      Biophytis has traded in the range of 0.0021 € to 1.40 € during the past year
      What is the PE ratio of Biophytis?
      The price to earnings ratio of Biophytis is -5.73
      What is the reporting currency for Biophytis?
      Biophytis reports financial results in EUR
      What is the latest annual profit for Biophytis?
      The latest annual profit of Biophytis is EUR -17.03M
      What is the registered address of Biophytis?
      The registered address for Biophytis is 14 AVENUE DE L’OPERA, PARIS, PARIS, 75001
      What is the Biophytis website address?
      The website address for Biophytis is www.biophytis.com
      Which industry sector does Biophytis operate in?
      Biophytis operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      DMSBSDiagnostic Medical Systems
      0.002 €
      (300.00%)
      		225.82k
      SEQUASequana medical NV
      2.07 €
      (170.94%)
      		3.67M
      ALMARMare Nostrum
      0.914 €
      (134.36%)
      		77.49k
      MLCOTCoretech 5
      0.012 €
      (50.00%)
      		96
      EIFDSTour Eiffel DS
      0.0048 €
      (50.00%)
      		5.35k
      ALTROTronic s Microsystems
      3.36 €
      (-31.15%)
      		21
      NICBSNicox SA
      0.013 €
      (-26.55%)
      		11.71k
      MLWEYWeya
      0.014 €
      (-26.32%)
      		74.37k
      MLOCTOctopus Biosafety
      0.125 €
      (-22.84%)
      		20.5k
      CNVCnova NV
      0.165 €
      (-21.05%)
      		12.16k
      ATOAtos SE
      0.0024 €
      (14.29%)
      		2.15B
      ALCYBCybergun
      0.0002 €
      (0.00%)
      		131.69M
      BCPBanco Comercial Portugues SA
      0.4503 €
      (0.22%)
      		26.89M
      BIOSBiosenic
      0.0061 €
      (-3.17%)
      		9.73M
      ALHGLouis Hachette Group
      1.3974 €
      (4.74%)
      		8.63M

      Discussion

      View Full Feed
      Hoghead7 Hoghead7 2 minutes ago
      The varying difference and volume levels remained consistent throughout the day. Volume below average on all but Ballard. Ballard closed up over 4% and Fuelcell up over 7% while Plug was down and Bloom was basically flat. We closed over $11 like I hoped, now we need to close over $12 ASAP, $12.60
      FCEL
      Stinger2014 Stinger2014 2 minutes ago
      Nice to be a landlord! $$$
      CGAC
      CommodityCoverage CommodityCoverage 4 minutes ago
      With the Trump administration's renewed focus on reshoring critical mineral supply chains, streamlining permitting processes, and investing in infrastructure like the proposed Ambler Road, the potential for a mining renaissance in Alaska is gaining momentum. This pro-mining stance could unlock unpre
      USGDF
      weedtrader420 weedtrader420 4 minutes ago
      XRP 💫WE ARE THE 🌎🌍🌏
      XRPUSD
      georgejjl georgejjl 4 minutes ago
      He doesn't understand the biology of the issue of ADCS-ADL for those with early Alzheimer's/MCI who have a baseline 20 =< MMSE
      AVXL
      mrfence mrfence 5 minutes ago
      Why keeping Fannie Mae and Freddie Mac in chains is a gamble.
      FNMA
      Clark6290 Clark6290 5 minutes ago
      Once my internet was restored I checked the commons closed in the red. Follow L2 and not silly childish pictures
      FNMA
      getmoreshares getmoreshares 7 minutes ago
      its a BID-- SMH- don't you know the difference? Hope you don't trade OTC- no wonder you lost money
      BCAP
      northam43 northam43 7 minutes ago
      Report #1 Status Report.

      https://investorshub.advfn.com/uimage/uploads/2024/12/23/dcxjb1_Status_Report.PNG
      doughnuthole doughnuthole 7 minutes ago
      Of course not lol. I'm on your side stop but I want to know why other other aren't and I think it's just ego. This is why I feel morely Superior to everyone else not just here but in real life because I have no problem admitting when I'm wrong and no one else can do that for some reason and I don't
      StayHumble StayHumble 8 minutes ago
      Great💹10M+ $HIRU XPERT💹BUYS💹 💹 💹https://ih.advfn.com/stock-market/USOTC/hiru-pk-HIRU/trades
      HIRU
      FROZENFLAME FROZENFLAME 8 minutes ago
      52WL play, interesting !
      KWE
      TenKay TenKay 8 minutes ago
      I am just curious…what is an example of said best in depth analysis.?
      HMBL
      Investor2014 Investor2014 10 minutes ago
      The two trials are certainly not directly comparable on endpoints and trial population baseline characteristics.

      I am more interested in a strong correlation between responder biological profiles between the biomarker results of the two trials - to the extend the datasets supports. I
      AVXL
      weedtrader420 weedtrader420 10 minutes ago
      I bought 🦭, looking good already XRP HBAR
      HBARUSD
      mick mick 10 minutes ago
      https://www.nasdaq.com/market-activity/stocks/ihgp

      About Interact Holdings Group Inc
      China

      Jun An Kang Group Inc formerly Interact Holdings Group Inc is engaged in the acquisition of long-term recurring revenue contracts.

      The company is also invol
      IHGP
      Lime Time Lime Time 11 minutes ago
      38m bid on Expert Market is very rare. His other one has a 55m bid on EM. It might be insiders in the know trying for end of year tax loss sellers. 2025 will be great here. I'm bidding with the insiders, currently why the heck not ❗️ 🤠
      BCAP
      Alley-oop Alley-oop 11 minutes ago
      It can easily hit 5 cents and 10 cents.
      SMCE
      Jay_B Jay_B 11 minutes ago
      Who knows. Makes no sense. It certainly could be turned into something. Maybe that Hi-Lo guy has an answer.
      SFLM
      CommodityCoverage CommodityCoverage 11 minutes ago
      Poised for a transformative year with the planned restart of mining operations at the La Colorada Mine in Mexico in January 2025, Heliostar Metals (HSTR.v HSTXF) is on track to make a significant step toward its ambition of becoming a mid-tier gold producer, targeting annual production between 100,0
      HSTXF
      goodietime goodietime 11 minutes ago
      And that estimate is early 2029.... I certainly hope we see something long before that:((
      COOP
      oldstocks oldstocks 11 minutes ago
      Afterhours Movers
      CREV
      NCRA
      BNOX
      MYNA
      TIVC
      TNXP
      EDBL
      RGTI
      PDYN
      BNOX EDBL NCRA
      awesomed007 awesomed007 12 minutes ago
      Pps is where it was before the big run up last fall. 🔮🤞
      SPZI
      northam43 northam43 13 minutes ago
      Report #2 December 2024 SPX Cycles

      https://investorshub.advfn.com/uimage/uploads/2024/12/23/ivzti2_Completed_Cycles.PNG

      Your Recent History

      EU
      ALBPS
      Biophytis
      TG
      5NQ
      Agilyx ASA
      BIT
      1SMCI
      Super Micro Computer
      BIT
      1BAS
      BASF
      BIT
      DM
      Digital Magics S.p.A
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads